Evidence map›Paper›PMID 21943421›Full record

ArticleBiophysical journal2011

Unlinking of supercoiled DNA catenanes by type IIA topoisomerases.

Alexander Vologodskii

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Mechanistic basis for relaxation of DNA supercoils by human topoisomerase IIIα-RMI1-RMI2.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. The many lives of type IA topoisomerases.The Journal of biological chemistry · 2020
    Review
  7. Review
  8. PICH and TOP3A cooperate to induce positive DNA supercoiling.Nature structural & molecular biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alexander VologodskiiDepartment of Chemistry, New York University, New York, New York, USA.
New York University · US

Funding

DNA CATENANES AND TYPE II DNA TOPOISOMERASESR01GM054215 · NIGMS · NEW YORK UNIVERSITY · PI VOLOGODSKII, ALEXANDER V · 1996 to 2010
$2.8M
NIGMS NIH HHS GM54215NIGMS NIH HHS R01 GM054215
6 · The paper itself

Abstract

It was found recently that DNA catenanes, formed during replication of circular plasmids, become positively (+) supercoiled, and the unlinking of such catenanes by type IIA topoisomerases proceeds much more efficiently than the unlinking of negatively (-) supercoiled catenanes. In an attempt to explain this striking finding we studied, by computer simulation, conformational properties of supercoiled DNA catenanes. Although the simulation showed that conformational properties of (+) and (-) supercoiled replication catenanes are very different, these properties per se do not give any advantage to (+) supercoiled over (-) supercoiled DNA catenanes for unlinking. An advantage became evident, however, when we took into account the established features of the enzymatic reaction catalyzed by the topoisomerases. The enzymes create a sharp DNA bend in the first bound DNA segment and allow for the transport of the second segment only from inside the bend to its outside. We showed that in (-) supercoiled DNA catenanes this protein-bound bent segment becomes nearly inaccessible for segments of the other linked DNA molecule, inhibiting the unlinking.

Indexed as

Models, MolecularNucleic Acid ConformationAntigens, NeoplasmDNA-Binding ProteinsDNA, SuperhelicalDNA Topoisomerases, Type IIAntigens, NeoplasmDNA-Binding ProteinsDNA, SuperhelicalDNA Topoisomerases, Type II

Identifiers

PMID21943421
PMCPMC3177067
OpenAlexW2071753578

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.